Repurposing Tranexamic Acid as an Anticancer Agent is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: R01 DK121831
National Institutes of Health
Grant: 5R01DK121831-04
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis
National Institutes of Health
Grant: 5R01NS102624-03
Optimizing AAV Vectors for Central Nervous System transduction
National Institutes of Health
Grant: 1R21CA252400-01
Regulation of Death Receptor 5 folding and apoptotic signaling by AGR2
National Institutes of Health
Grant: 1S10OD021758-01A1
Acquisition of a Q Exactive HF Hybrid Quadrupole-Orbitrap
FWCI
1.34
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals